BLT, RUA, AFT: Pharma stocks as govt unveils new healthcare system

As the market participants are aware, the global economy witnessed the negative impacts as a result of the outbreak of COVID-19 pandemic. The lockdowns impacted the operations of several companies. However, some companies could now perform well. This...

Highlights Pacific Edge uses Cxbladder to detect and manage bladder cancer. Northland and Taranaki District Health Boards in NZ have adopted a full set of Cxbladder tests. American Urology Association published a lookback study to highlight th...

Highlights Amid the vaccination rollout and emerging Delta cases, retirement villages are under the spotlight. Recently, Summerset Group noted a robust third-quarter 2021 both in new and resales. Last month, Oceania made 2 new additions to it,...

Around the world, healthcare companies have been putting in an effort to battle the COVID-19 pandemic. There have been major attempts worldwide to detect, cure and stop the spread of infection emerging from coronavirus.     &nbs...

Highlights Fisher & Paykel Healthcare Corporation has introduced, the Evora Full, its compact full-face mask. The said mask which comes in three sizes would initially be available in New Zealand and Australia. Fisher & Paykel Healt...

Highlights COGA evaluation, YTD sales growth noted by TruScreen. Management changes and additions made to Blis Technologies and Fisher and Paykel’s Board. GMP Manufacturing licence received by Rua Bioscience. The healthcare industry...

Highlights Oceania Healthcare provided an update on big management changes. Third Age Care announces a change in the settlement for acquisition. A banking covenant break announced by Promisia. The sudden surge of the delta variant of COVI...

Highlights Retail offer announced by Pacific Edge for its New Zealand shareholders. Offer made as an extension to its Australia placement. Capital raised will help in funding the future vision for the Company. Pacific Edge Limited (NZX:PE...

Highlights Pacific Edge concludes its capital raise of NZ$80 million. Cxbladder products’ outperformance a reason for a surge in demand. This could mean further growth for the Company in the future. In a recent announcement, Pacific...

Highlights The healthcare sector saw major changes and action in the pandemic-stricken world. Management additions done by Oceania Healthcare. Ryman Healthcare’s Chief Development Officer Jeremy Moore went through the role change. T...